Cellosaurus WIL2 NS (CVCL_2761)
Cell line name | WIL2 NS | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | WIL2-NS; WIL-2NS; WIL-2-NS; WI-L2-NS; WI-L2 NS; WIL2NS; WIL2 Non-Secreting | ||||||||||||||||||||||||||
Accession | CVCL_2761 | ||||||||||||||||||||||||||
Resource Identification Initiative | To cite this cell line use: WIL2 NS (RRID:CVCL_2761) | ||||||||||||||||||||||||||
Comments | Group: Hybridoma fusion partner cell line. Group: Patented cell line. Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). Part of: COSMIC cell lines project. Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8155. Population: Caucasian. Characteristics: Does not secrete immunoglobulins. Microsatellite instability: Stable (MSS) (Sanger). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Omics: Deep exome analysis. Omics: Deep quantitative proteome analysis. Omics: DNA methylation analysis. Omics: SNP array analysis. Omics: Transcriptome analysis by microarray. Derived from site: In situ; Spleen; UBERON=UBERON_0002106. | ||||||||||||||||||||||||||
Sequence variations |
| ||||||||||||||||||||||||||
HLA typing | Source: IPD-IMGT/HLA=11561
| ||||||||||||||||||||||||||
Genome ancestry | Source: PubMed=30894373
| ||||||||||||||||||||||||||
Disease | Hereditary spherocytosis (NCIt: C97074) Hereditary spherocytosis (ORDO: Orphanet_822) | ||||||||||||||||||||||||||
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||||||||||||||||||||||||||
Hierarchy | Parent: CVCL_6544 (WIL2) Children:
| ||||||||||||||||||||||||||
Sex of cell | Male | ||||||||||||||||||||||||||
Age at sampling | 5Y | ||||||||||||||||||||||||||
Category | Transformed cell line | ||||||||||||||||||||||||||
STR profile | Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; RCB Markers:
Run an STR similarity search on this cell line | ||||||||||||||||||||||||||
Publications | Patent=US4806476 PubMed=1677771; DOI=10.1073/pnas.88.15.6652 PubMed=7798274; DOI=10.1016/S0021-9258(18)31687-9 PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458 PubMed=27397505; DOI=10.1016/j.cell.2016.06.017 PubMed=29892436; DOI=10.1098/rsos.172472 PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747 PubMed=33198927; DOI=10.1016/j.mrgentox.2020.503236 PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010 | ||||||||||||||||||||||||||
Cross-references | |||||||||||||||||||||||||||
Cell line collections (Providers) | ATCC; CRL-8155
ECACC; 90112121 JCRB; JCRB9063 RCB; RCB2285 - Discontinued TKG; TKG 0374 - Discontinued | ||||||||||||||||||||||||||
Cell line databases/resources | CLO; CLO_0009601
CLO; CLO_0009604 CLDB; cl4717 cancercelllines; CVCL_2761 Cell_Model_Passport; SIDM01102 Cosmic-CLP; 1331049 DepMap; ACH-002316 IPD-IMGT/HLA; 11561 | ||||||||||||||||||||||||||
Anatomy/cell type resources | BTO; BTO:0001524 | ||||||||||||||||||||||||||
Biological sample resources | BioSample; SAMN03471196
BioSample; SAMN03472416 | ||||||||||||||||||||||||||
Chemistry resources | ChEMBL-Cells; CHEMBL3308012
ChEMBL-Targets; CHEMBL612810 GDSC; 1331049 PharmacoDB; WIL2NS_1661_2019 PubChem_Cell_line; CVCL_2761 | ||||||||||||||||||||||||||
Encyclopedic resources | Wikidata; Q54994065 | ||||||||||||||||||||||||||
Gene expression databases | ArrayExpress; E-MTAB-3610
GEO; GSM827461 GEO; GSM1670575 GEO; GSM4288411 | ||||||||||||||||||||||||||
Polymorphism and mutation databases | IARC_TP53; 4041
Progenetix; CVCL_2761 | ||||||||||||||||||||||||||
Proteomic databases | PRIDE; PXD030304 | ||||||||||||||||||||||||||
Sequence databases | EGA; EGAS00001000978 | ||||||||||||||||||||||||||
Entry history | |||||||||||||||||||||||||||
Entry creation | 04-Apr-2012 | ||||||||||||||||||||||||||
Last entry update | 05-Oct-2023 | ||||||||||||||||||||||||||
Version number | 33 |